Skip to main content

Advertisement

Log in

A retrospective review of outcomes in the treatment of hyperammonemia with renal replacement therapy due to inborn errors of metabolism

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Outcomes for severe hyperammonemia treated with renal replacement therapy (RRT) reported in the literature vary widely. This has created differing recommendations regarding when RRT is beneficial for hyperammonemic patients.

Methods

To evaluate our institution’s experience with RRT in pediatric patients with inborn errors of metabolism (IEMs) and potential prognostic indicators of a better or worse outcome, we performed a retrospective chart review of patients who received RRT for hyperammonemia. Our cohort included 19 patients with confirmed IEMs who received RRT between 2000 and 2017. Descriptive statistics are presented as medians with interquartile ranges with appropriate statistical testing assuming unequal variance.

Results

There were 16 males (84%) and 3 females (16%) identified for inclusion in this study. There were 9 survivors (47%) and 10 non-survivors (53%). The average age of survivors was 67 months (age range from 3 days to 15.6 years). The average age of non-survivors was 1.8 months (age range from 2 days to 18.7 months). Peak ammonia, ammonia on admission, and at RRT initiation were higher in non-survivors compared with survivors. Higher ammonia levels and no change in ammonia between admission and RRT initiation were associated with an increased risk of mortality.

Conclusions

Hyperammonemia affects two distinct patient populations; neonates with markedly elevated ammonia levels on presentation and older children who often have established IEM diagnoses and require RRT after failing nitrogen-scavenging therapy. Our experience demonstrates no significant change in mortality associated with neonatal hyperammonemia, which remains high despite improvements in RRT and intensive care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data presented in this submission is available upon request after de-identification beginning 3 months and ending 5 years following article publication. Proposals should be directed to corresponding author. To gain access, data requestors will need to sign a data access agreement and provide a methodologically sound proposal.

Abbreviations

RRT:

Renal replacement therapy

PD:

Peritoneal dialysis

HD:

Hemodialysis

CRRT:

Continuous renal replacement therapy

IEM:

Inborn error of metabolism

UCD:

Urea cycle disorder

OA:

Organic acidemia

GFR:

Glomerular filtration rate

References

  1. Bachmann C (2003) Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr 162(6):410–416

    Article  Google Scholar 

  2. Nassogne MC, Héron B, Touati G, Rabier D, Saudubray JM (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28(3):407–414

    Article  CAS  Google Scholar 

  3. Msall M, Batshaw M, Suss R, Brusilow S, Mellits ED (1984) Neurologic outcome in children with inborn error of urea synthesis. N Engl J Med 310:1500–1505

    Article  CAS  Google Scholar 

  4. Maestri NE, Hauser ER, Bartholomew D, Brusilow SW (1991) Prospective treatment of urea cycle disorders. J Pediatr 119(6):923–928

    Article  CAS  Google Scholar 

  5. Unsinn C, Das A, Valayannopoulos V, Thimm E, Beblo S, Burlina A et al (2016) Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013. Orphanet J Rare Dis 11(1):1–11

    Article  Google Scholar 

  6. Burgard P, Kölker S, Haege G, Lindner M, Hoffmann GF (2016) Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders—review and meta-analysis of observational studies published over more than 35 years. J Inherit Metab Dis 39(2):219–229

    Article  Google Scholar 

  7. Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M et al (2012) Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis 35(5):777–785

    Article  CAS  Google Scholar 

  8. Krivitzky L, Babikian T, Lee HS, Thomas NH, Burk-Paull KLBM (2009) Intellectual, adaptive, and behavioral functioning in children with urea cycle disorders. Pediatr Res 66(1):96–101

    Article  CAS  Google Scholar 

  9. Surtees RA, Matthews EE, Leonard JV (1992) Neurologic outcome of propionic acidemia. Pediatr Neurol 8(5):333–337

    Article  CAS  Google Scholar 

  10. McBryde KD, Kershaw DB, Bunchman TE, Maxvold NJ, Mottes TA, Kudelka TL et al (2006) Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr 148(6):770–778

    Article  Google Scholar 

  11. Picca S, Dionisi-Vici C, Abeni D, Pastore A, Rizzo C, Orzalesi M et al (2001) Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 16(11):862–867

    Article  CAS  Google Scholar 

  12. Hediger N, Landolt MA, Diez-Fernandez C, Huemer M, Häberle J (2018) The impact of ammonia levels and dialysis on outcome in 202 patients with neonatal onset urea cycle disorders. J Inherit Metab Dis 41(4):689–698

    Article  CAS  Google Scholar 

  13. Donn SM, Swartz RD, Thoene JG (1979) Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. J Pediatr 95(1):67–70

    Article  CAS  Google Scholar 

  14. Wong KY, Wong SN, Lam SY, Tam S, Tsoi NS (1998) Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration. Pediatr Nephrol 12(7):589–591

    Article  CAS  Google Scholar 

  15. Picca S, Dionisi-Vici C, Bartuli A, De Palo T, Papadia F, Montini G et al (2015) Short-term survival of hyperammonemic neonates treated with dialysis. Pediatr Nephrol 30(5)

  16. Pela I, Seracini D, Donati MA, Lavoratti G, Pasquini E, Materassi M (2008) Peritoneal dialysis in neonates with inborn errors of metabolism: is it really out of date? Pediatr Nephrol 23(1):163–168

    Article  Google Scholar 

  17. Häberle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M et al (2019) Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis 42(6):1192–1230

    Article  Google Scholar 

  18. Cho H (2019) Renal replacement therapy in neonates with an inborn error of metabolism. Korean J Pediatr 62(2):43–47

    Article  CAS  Google Scholar 

  19. Demirkol D, Aktuğlu Zeybek Ç, Karacabey BN, Cesur Y, Ataman Y, Soysal E (2019) The role of supportive treatment in the management of hyperammonemia in neonates and infants. Blood Purif:1–8

  20. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 58(2):259–263

    CAS  PubMed  Google Scholar 

  21. Su SW, Stonestreet BS (2010) Core concepts: neonatal glomerular filtration rate. Neoreviews. 11(12):e714–e721

    Article  Google Scholar 

  22. Ripley B, Venables B, Bates D, Hornik K, Gebhardt A, Firth D. MASS: Modern Applied Statistics with S [Internet]. R package version 3.5.1. 2019. Available from: https://cran.r-project.org/package=MASS

  23. Aragon T, Fay M, Wollschlaeger D, Omidpanah A. Epitools: Epidemiology Tools [Internet]. R package version 3.5.1. 2017. Available from: https://cran.r-project.org/package=epitools

  24. Wickham H, Chang W, Henry L, Pedersen T, Takahashi K, Wilke C, et al. ggplot2: Create elegant data visualisations using the grammar of graphics [Internet]. R package version 3.5.1. 2019. Available from: https://cran.r-project.org/package=ggplot2

  25. Porta F, Peruzzi L, Bonaudo R, Pieretti S, Busso M, Cocchi E et al (2018) Differential response to renal replacement therapy in neonatal-onset inborn errors of metabolism. Nephrol. 23(10):957–961

    Article  CAS  Google Scholar 

  26. Held PK, Haynes CA, De Jesús VR, Baker MW (2014) Development of an assay to simultaneously measure orotic acid, amino acids, and acylcarnitines in dried blood spots. Clin Chim Acta 436:149–154

    Article  CAS  Google Scholar 

  27. Janzen N, Terhardt M, Sander S, Demirkol M, Gökçay G, Peter M et al (2014) Towards newborn screening for ornithine transcarbamylase deficiency: fast non-chromatographic orotic acid quantification from dried blood spots by tandem mass spectrometry. Clin Chim Acta 430:28–32

    Article  CAS  Google Scholar 

  28. Vergano SA, Crossette JM, Cusick FC, Desai BR, Deardorff MA, Sondheimer N (2013) Improving surveillance for hyperammonemia in the newborn. Mol Genet Metab 110(1–2):102–105

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elizabeth G. Ames.

Ethics declarations

Conflict of interest

There are no conflicts of interest for the authors.

Prior presentation of data

Subsets of the data reported in this manuscript have been presented at annual meetings of the Pediatric Academic Society in 2015 and the American College of Medical Genetics in 2018.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ames, E.G., Luckritz, K.E. & Ahmad, A. A retrospective review of outcomes in the treatment of hyperammonemia with renal replacement therapy due to inborn errors of metabolism. Pediatr Nephrol 35, 1761–1769 (2020). https://doi.org/10.1007/s00467-020-04533-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-020-04533-3

Keywords

Navigation